← Legend Biotech Corp
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | $49.1m |
$57.3m
+16.55%
|
$75.7m
+32.15%
|
$68.8m
-9.05%
|
$127.7m
+85.55%
|
$285.1m
+123.28%
|
$627.2m
+119.97%
|
$1.0b
+64.04%
|
$1.1b
+10.70%
|
|
| License and other revenue | — | — | — | — | — | — | $35.3m | $144.7m | $84.1m | — | |
| Collaboration revenue | — | — | — | $0 | $0 | $66.7m | $249.8m | $482.6m | $944.8m | — | |
| Cost of collaboration revenue | — | — | — | $0 | $0 | ($65.4m) | ($144.2m) | ($216.4m) | ($397.1m) | — | |
| Cost of license and other revenue | — | — | — | — | — | $0 | $0 | ($18.2m) | ($11.0m) | — | |
| Cost of Goods and Services Sold | — | $22.1m |
$25.7m
+16.55%
|
$34.0m
+32.15%
|
$30.9m
-9.05%
|
$65.4m
+111.59%
|
$144.2m
+120.64%
|
$216.4m
+50.03%
|
$397.1m
+83.53%
|
$512.7m
+29.11%
|
|
| Cost Of Revenue | — | — | — | — | — | $65.4m |
$144.2m
+120.61%
|
$234.6m
+62.69%
|
$408.1m
+73.96%
|
$512.7m
+25.63%
|
|
| Net Interest Income | — | — | — | — | — | ($2.6m) |
$32.7m
+1350.96%
|
$39.6m
+21.10%
|
$18.7m
-52.78%
|
$13.5m
-27.81%
|
|
| Gross Profit | — | $27.1m |
$31.6m
+16.55%
|
$41.7m
+32.15%
|
$37.9m
-9.05%
|
$51.6m
+36.13%
|
$140.9m
+172.84%
|
$392.7m
+178.71%
|
$620.8m
+58.09%
|
$626.3m
+0.89%
|
|
| Gross Profit (Calculated) | — | $27.1m |
$31.6m
+16.55%
|
$41.7m
+32.15%
|
$37.9m
-9.05%
|
$51.6m
+36.13%
|
$140.9m
+172.90%
|
$410.9m
+191.55%
|
$631.8m
+53.77%
|
— | |
| Research and development | — | $60.6m | $161.9m | $232.2m | $313.3m | $335.6m | $382.2m | $413.5m | $414.7m | $398.5m | |
| Selling And Marketing Expense | — | — | — | — | — | $93.4m | $94.2m | $147.5m | $205.8m | $359.2m | |
| General And Administrative Expense | — | $2.8m | $6.8m | $23.1m | $47.0m | $80.6m | $106.8m | $136.8m | $135.8m | $144.3m | |
| Operating expenses: | |||||||||||
| Other Operating Expenses | — | — | — | — | — | ($2.4m) | $85.8m | $4.4m | $1.0m | — | |
| Operating loss | — | — | — | — | — | ($434.9m) |
($528.1m)
-21.42%
|
($309.5m)
+41.39%
|
($136.5m)
+55.90%
|
($134.6m)
+1.39%
|
|
| Other Non Operating Income Expenses | — | — | — | — | — | ($9.0m) | $3.4m | $2.5m | $4.0m | — | |
| Interest Expense On Lease Liabilities | — | — | $199k | $195k | $142k | $527k | $1.4m | $1.8m | $3.5m | $21.8m | |
| Interest Expense | — | ($82k) | $223k | $4.2m | $900k | $10.8m | $21.8m | $21.6m | $21.4m | $21.8m | |
| Interest Income | — | — | $4.6m | $2.9m | $971k | $8.2m | $54.5m | $61.2m | $40.1m | $35.3m | |
| Net Non Operating Interest Income Expense | — | — | — | — | — | ($2.6m) | $32.7m | $39.6m | $18.7m | $13.5m | |
| Gain On Sale Of Security | — | — | — | — | — | $21.5m | ($28.2m) | $109.3m | ($168.8m) | ($119.5m) | |
| Other Income | — | — | $7.1m | $6.1m | $2.7m | $10.7m | $57.5m | $63.7m | — | — | |
| Other Income Expense | — | — | — | — | — | $12.5m | ($24.8m) | $111.8m | ($164.8m) | ($115.4m) | |
| Pre-Tax Income | — | ($1.6m) | ($130.4m) | ($307.6m) | ($407.2m) | ($445.7m) | ($520.2m) | ($158.1m) | ($282.6m) | ($236.5m) | |
| Deferred Tax Expense (Income) Recognised In Profit Or Loss | — | — | ($68.9m) | — | ($8.0m) | — | — | — | — | — | |
| Income Tax Expense Continuing Operations | — | $1.2m | $2.6m | ($4.1m) | ($3.6m) | $625k | ($1.9m) | $18.9m | $14.2m | $13.6m | |
| Net loss | — | ($2.8m) | ($133.0m) | ($303.5m) | ($386.2m) | ($446.3m) | ($518.3m) | ($177.0m) | ($296.8m) | — | |
| Net Income From Continuing And Discontinued Operation | — | ($2.8m) | ($133.0m) | ($303.5m) | ($386.2m) | ($446.3m) | ($518.3m) | ($177.0m) | ($296.8m) | ($250.1m) | |
| Basic Earnings (Loss) Per Share | — | ($0.01) | ($0.66) | ($1.28) | ($1.43) | ($1.40) | ($1.47) | ($0.48) | ($0.81) | ($1.38) | |
| Diluted Earnings (Loss) Per Share | — | ($0.01) | ($0.66) | ($1.28) | ($1.43) | ($1.40) | ($1.47) | ($0.48) | ($0.81) | ($1.38) | |
| Basic Average Shares | — | — | — | — | — | $159.0m | $176.1m | $182.9m | $184.3m | $184.7m | |
| Diluted Average Shares | — | — | — | — | — | $159.0m | $176.1m | $182.9m | $184.3m | $184.7m | |
| Additional Financial Items | |||||||||||
| Average Effective Tax Rate | — | — | ($0) | $0 | $0 | ($0) | $0 | ($0) | ($0) | — | |
| Depreciation Right of Use Assets | — | — | $1.2m | $1.5m | $4.4m | $5.7m | $7.8m | $10.7m | $19.5m | — | |
| Finance Income | — | — | $4.6m | $2.9m | $971k | $8.2m | $54.5m | $61.2m | $40.1m | — | |
| Impairment Loss Recognised In Profit Or Loss Property Plant And Equipment Including Right of Use Assets | — | — | — | — | — | — | — | $4.4m | $1.0m | — | |
| Profit Loss Attributable To Owners Of Parent | — | — | ($133.0m) | ($303.5m) | ($403.6m) | ($446.3m) | ($518.3m) | ($177.0m) | — | — | |
| Profit Loss Before Tax | — | ($1.6m) | ($130.4m) | ($307.6m) | ($407.2m) | ($445.7m) | ($520.1m) | ($158.1m) | ($282.6m) | — | |
| Profit Loss From Operating Activities | — | — | — | — | — | — | — | — | ($136.5m) | — | |
| Tax Rate Effect Of Foreign Tax Rates | — | — | ($0) | ($0) | ($0) | ($0) | ($0) | — | — | — | |
| Exchange differences on translation of foreign operations | — | ($1.4m) | $182k | ($2.1m) | $10.6m | $9.8m | $29.6m | ($112.5m) | $190.4m | — | |
| Other comprehensive income/(loss), net of tax | — | ($1.4m) | $182k | ($2.1m) | $10.6m | $9.8m | $29.6m | ($112.5m) | $190.4m | — | |
| Diluted EPS | — | — | — | — | — | ($2.80) | ($2.94) | ($0.96) | ($1.62) | ($1.38) | |
| Diluted NI Availto Com Stockholders | — | ($2.8m) | ($133.0m) | ($303.5m) | ($386.2m) | ($446.3m) | ($518.3m) | ($177.0m) | ($296.8m) | ($250.1m) | |
| Impairment Of Capital Assets | — | — | — | — | — | $0 | $0 | $4.4m | — | $5.4m | |
| Normalized EBITDA | — | — | — | — | — | ($438.0m) | ($451.7m) | ($224.4m) | ($63.5m) | ($175.3m) | |
| Normalized Income | — | — | — | — | — | ($463.3m) | ($490.2m) | ($263.3m) | ($163.4m) | ($178.4m) | |
| Other Gand A | — | $2.8m | $6.8m | $23.1m | $47.0m | $80.6m | $106.8m | $136.8m | $135.8m | — | |
| Reconciled Depreciation | — | — | — | — | — | $18.4m | $18.5m | $21.4m | $28.9m | $39.4m | |
| Selling General And Administration | — | — | — | — | — | $174.0m | $201.0m | $284.3m | $341.6m | — | |
| Special Income Charges | — | — | — | — | — | $0 | $0 | ($4.4m) | — | ($5.4m) | |
| Tax Effect Of Unusual Items | — | — | — | — | — | $4.5m | ($103k) | $23.0m | ($35.4m) | ($47.8m) | |
| Tax Provision | — | — | — | — | — | $625k | ($1.9m) | $18.9m | $14.2m | $13.6m | |
| Tax Rate For Calcs | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Write Off | — | — | — | — | — | $0 | $0 | $4.4m | — | $4.4m | |
| Administrative Expense | — | $2.8m | $6.8m | $23.1m | $47.0m | $80.6m | $106.8m | $136.8m | $135.8m | — | |
| Employee Benefits Expense | — | — | — | — | — | — | — | $391.6m | $492.3m | — | |
| Expense From Share-Based Payment Transactions With Employees | — | — | $1.3m | $4.8m | $20.2m | $34.3m | $47.7m | $68.9m | $64.6m | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | — | $272k | $69k | $182k | $1.1m | $2.3m | $3.5m | $3.7m | — | |
| Finance Costs | — | ($82k) | $223k | $4.2m | $900k | $10.8m | $21.8m | $21.6m | $21.4m | — | |
| Other Employee Expense | — | — | — | — | — | — | — | $9.9m | $10.6m | — | |
| Selling and distribution expenses | — | ($1.2m) | ($25.6m) | ($49.6m) | ($102.5m) | ($93.4m) | ($94.2m) | ($147.5m) | ($205.8m) | — | |
| Other (expense)/ income, net | — | — | — | — | — | — | ($24.8m) | $111.8m | ($164.8m) | — | |
| Operating Expense | — | — | — | — | — | $507.3m | $669.0m | $702.2m | $757.3m | $760.9m | |
| TOTAL COMPREHENSIVE LOSS | ($4.2m) | ($132.8m) | ($305.6m) | ($375.6m) | ($436.5m) | ($488.6m) | ($289.5m) | ($106.4m) | |||
| Total Unusual Items | — | — | — | — | — | $21.5m | ($28.2m) | $109.3m | ($168.8m) | ($119.5m) | |
| Total Expenses | — | — | — | — | — | $572.6m | $813.2m | $936.8m | $1.2b | $1.3b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.